117 results on '"Van De Vrande, Vareska"'
Search Results
2. Closing the Innovation Performance Gap: OPEN INNOVATION IN MILITARY BUREAUCRACIES.
3. The interdependent influence of lobbying and intellectual capital on new drug development
4. Technology transfer from public research institutes to SMEs: A configurational approach to studying reverse knowledge flow benefits
5. The evolving nature of open innovation governance: A study of a digital platform development in collaboration with a big science centre
6. Beggars can be choosers: Resource scarcity, dynamism, search activities, and their joint impact on performance
7. Closing the Innovation Performance Gap:Open Innovation in Military Bureaucracies
8. When opposites attract: a review and synthesis of corporate-startup collaboration.
9. Value creation in interdependent digital and analogue markets.
10. Spend it Wisely: Market and Non-market Strategies in the Development of New Drugs
11. Balancing exploration and exploitation in inventions: Quality of inventions and team composition
12. When opposites attract: a review and synthesis of corporate-startup collaboration
13. Corporate Venture Capital Investment Practices and the Exit Puzzle
14. Getting Away With It: How Do Firms Avoid Damage to Their Network After Allegations of Misconduct?
15. SPEND IT WISELY: MARKET AND NON-MARKET STRATEGIES IN THE DEVELOPMENT OF NEW DRUGS.
16. BALANCING YOUR TECHNOLOGY-SOURCING PORTFOLIO: HOW SOURCING MODE DIVERSITY ENHANCES INNOVATIVE PERFORMANCE
17. Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?
18. The evolving nature of open innovation governance:A study of a digital platform development in collaboration with a big science centre
19. sj-docx-1-oss-10.1177_01708406211058640 ��� Supplemental material for Embracing Paradox: TMT paradoxical processes as a steppingstone between TMT reflexivity and organizational ambidexterity
20. Embracing Paradox: TMT paradoxical processes as a steppingstone between TMT reflexivity and organizational ambidexterity
21. Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?
22. Embracing Paradox: TMT paradoxical processes as a steppingstone between TMT reflexivity and organizational ambidexterity.
23. Exploring Open Innovation in Small and Medium-Sized Enterprises
24. Open innovation in SMEs: Trends, motives and management challenges
25. How prior corporate venture capital investments shape technological alliances: a real options approach
26. Beggars can be choosers:Resource scarcity, dynamism, search activities, and their joint impact on performance
27. GETTING AWAY WITH EXPECTANCY VIOLATIONS: HOW DO FIRMS AVOID DAMAGE TO THEIR NETWORK AFTER ALLEGATIONS OF MISCONDUCT?
28. 'Pulling the plug”: Time allocation between drug discovery and development projects
29. The Evolving Nature of Open Innovation Governance: A Study of a Digital Platform Development in Collaboration with a Big Science Centre
30. “Pulling the Plug:” Time Allocation between Drug Discovery and Development Projects
31. Governing Open Innovation and a Digital Platform in Collaboration with a Big Science Center
32. External technology sourcing: The effect of uncertainty on governance mode choice
33. Choosing governance modes for external technology sourcing
34. The role of intellectual capital in new product development: Can it become a liability?
35. Tapping into the knowledge of incumbents: The role of corporate venture capital investments and inventor mobility
36. The Extent of Corporate Venturing and Firm Performance: The Mediating Role of Portfolio Strategies
37. The role of intellectual capital in new product development: Can it become a liability?
38. I Think We Should See Other People: The Impact of Network Turnover on VC Investment Performance.
39. Is it better to look inside or outside for innovation?
40. Solopreneurs and the rise of co-working in the Netherlands
41. Tapping into the knowledge of incumbents: The role of corporate venture capital investments and inventor mobility
42. Dimensions of Dependence: An Analysis of Entrepreneurial Ventures Ties to Established Corporations
43. Collaborative Innovation: Creating Opportunities in a Changing World
44. Syndicate Composition and Value Creation for Entrepreneurial Ventures: Looking Beneath the Surface
45. Tapping into the knowledge of incumbents: The role of corporate venture capital investments and inventor mobility.
46. Who is the corporate entrepreneur? Insights from opportunity discovery and creation theory
47. Exploring Open Innovation in Small and Medium-Sized Enterprises
48. When going Dutch means a free lunch: how Australians could build social capital
49. Patent Examiners As Knowledge Brokers: The Role Of Examiner-Added Citations
50. Embracing Paradox: Paradoxical Cognition as Mediating Factor Between Reflexivity and Ambidexterity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.